Indian Pharmaceutical Alliance Calls for a Stronger U.S.-India Partnership for Affordable Medicine
May 08, 2024
New Delhi [India], May 8: The Indian Pharmaceutical Alliance (IPA)-comprising 23 leading Indian research-based generic pharmaceutical companies - convened today at the DAR Museum in Washington DC to urge a U.S.-India trade partnership to reduce reliance on foreign sources for both nation's pharmaceutical supply chain and achieve affordable medicine resilience. These leaders cited a key new study released by IQVIA Institute for Human Data Science https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-india-medicine-partnership - U.S. - India Medicine Partnership: India's Contributions to U.S. Healthcare - highlighting India's vital contribution to the U.S. healthcare system, and the significance of the U.S.-India relationship for strengthening the health security of both countries.